To kick off the Symposium, Bill Burns of Conning will walk us through the state of the MPL market by discussing the 2019 MPL insurance industry financial results, the key drivers of these results, perspectives on the challenges MPL insurers are facing, and Conning’s view of what the future might hold for the MPL market.
Through several perspectives including underwriting, brokerage, claims, and reinsurance claims, this session will explore several medical malpractice claims issues, including claim severity and verdict trend analysis as well as batch claim severity. Leave this session with a better understanding of what is driving med mal claim severity and what these claims issues mean to the med mal community.
ECO/XPL claims have long been a difficult area to navigate for insureds, primary carriers, and reinsurers alike - this session will provide an overview of the common issues and dive into how recent severity trends and developing exposures are impacting this already-fraught area.
This session will explore the current state of expansion with the use of advanced care practice professionals in the U.S. Attendees will gain a working knowledge of the types of claims and underwriting concerns that can be anticipated as this practice group grows and will become familiar with risk management strategies that can be successfully implemented. This session is not CE/CLE eligible.
How are novel liability issues arising from the use of artificial intelligence (A.I.) in healthcare being addressed? Our interactive discussion will discuss the impact that A.I. has on healthcare liability, how healthcare providers can adequately address potential A.I. liability through insurance, and the likely evolution of A.I. liability and the corresponding development of responsive insurance products. This session is not CE/CLE eligible.
This session will dive into the evolution of cyber coverage in the Healthcare sector from regulatory liability to all our warfare against nefarious attacks. Additional topics to be discussed include pre-claims management, the anatomy of a claim, and what risks you should be prepared for in the future.
Telehealth is dramatically changing the delivery of healthcare with its' ability to offer lower costs and easy access to care. This session will focus on key points for the MPL insurance industry including the MPLI industry opportunity, coverage issues, regulatory and liability risk, and some brief MPL case examples. This session is not CE/CLE eligible.
This session will focus on the emerging technology of stem cell procedures and as this is an evolving area of medicine, one of the main challenges that underwriters face is the difficulty in deciphering true science from the hype and marketing. We will explore the current FDA approved procedures, off-label use, cell banking, and autologous therapy. As with any new procedure, there is a learning curve and there is not a lot of claims experience to date. This session will also discuss specific areas of underwriting risk including non-approved procedures, informed consent, training, and provider and patient expectations. This session is not eligible for CE/CLE.
The long-term care industry can be challenging for investors, operators, and providers. This session will explore those challenges including underwriting and pricing concerns as well as changing defense strategies and recent verdicts. This session will examine how the model of care and venue impact severity and frequency and work to answer the question: how does the insurance industry reconcile the hardening market with the ever-increasing assumption of liability?
Clinicians and healthcare entities are dealing every day with an overwhelming amount of data -- data that relates to each patient requiring care, every transaction that enables that care, and myriad other factors that may or may not need immediate attention. In this "big data" environment, clinicians have difficulty sorting out what intel reflects true priorities versus data points that may have less criticality. Malpractice data is not often brought into the mix, largely because these data sets are siloed away from other data sets routinely reviewed in the healthcare settings. Yet, malpractice data has inherent value to clinicians, practices, and hospitals -- it serves as critical "signal data" -- shining a light on where vulnerabilities have existed in the past, and appropriately posing the question as to whether those problems are still at play. The goal of this session is to explore the unique value of deeply analyzed malpractice claims in serving as a "divining rod" for much larger data sets -- adverse events, patient complaints, and patient satisfaction.
CMS has developed a goal to have 100% of Medicare providers in a down-side risk arrangement by 2025. In addition, an increasing number of Commercial & Medicare Advantage plans are developing risk based capitated and bundled payment contracts. As providers are required to enter into these Value Based Care (VBC) contracts, their leadership teams are seeking ways to reduce their risk by purchasing stop-loss policies and through strategic ways to improve their outcomes, reduce the overall cost of care. This session will focus on new payment programs and contracts that are emerging and strategies for how provider organizations can better understand their exposure and limit their risk within these contracts. This session is not CE/CLE eligible.
An increasing appetite from US consumers for nutraceuticals is having significant implications for the life sciences insurance space. Estimates on the size of the US nutraceuticals market vary from USD 90B to USD150B – and it's only getting bigger. CBD (Cannabidiol) is the newest entrant to an already crowded party. What is nutraceutical marketing promising, what is it delivering, what is being regulated and what makes them risky? Join this interactive discussion to work through these questions and their impact on medical and allied health providers today. This session is not CE/CLE eligible.
The U.S. MPL market, mirroring the U.S. healthcare provider market that it serves, has undergone profound change over the last several years. Solo and small group independent physicians, traditionally the largest customer segment for MPL specialist carriers, have consolidated into larger (in some cases multi-state) groups, or have been absorbed into large health care systems as employees. With this vast increase in scope and scale, the “Buyer’s Perspective” has changed dramatically vs. 20 years ago, the last time the market underwent a significant, loss cost inflation-driven pricing correction. The session will focus on three primary areas: 1) what today’s buyer of MPL risk transfer seeks as far as products, services and expertise, 2) how MPL carriers have responded to this changing dynamic, and 3) how evolving areas, such as value-based care, may potentially impact and increase the size and scope of risk transfer from health care providers to (re)insurers.
The current regulatory environment is a challenging minefield of dos and don’ts. This session will explore products/professional liability, what questions you should be asking and how policies MAY or MAY not respond from an underwriting perspective. Join us for a lively discussion around the hottest topic in any industry! This session is not CE/CLE eligible.